DOI QR코드

DOI QR Code

Primary Cutaneous Mucinous Carcinoma Treated with Narrow Surgical Margin

  • Choi, Jin-Hee (Department of Plastic and Reconstructive Surgery, Yonsei University Wonju College of Medicine) ;
  • Kim, Seung Chan (Department of Plastic and Reconstructive Surgery, Yonsei University Wonju College of Medicine) ;
  • Kim, Jiye (Department of Plastic and Reconstructive Surgery, Yonsei University Wonju College of Medicine) ;
  • Chung, Yoon Kyu (Department of Plastic and Reconstructive Surgery, Yonsei University Wonju College of Medicine)
  • Received : 2016.05.17
  • Accepted : 2016.08.16
  • Published : 2016.09.20

Abstract

Primary cutaneous mucinous carcinoma (PCMC) is a rare malignant tumor of eccrine origin. Clinically, the carcinoma presents as a solitary, slow growing, and painless nodule. For this reason, this tumor is often considered to be a benign mass in the preoperative setting. The lesion is, however, malignant in nature and has a tendency for local recurrence and infrequent metastasis. Wide local excision is the treatment of choice. However, few reports exist with information regarding surgical margins and clinical outcomes. Herein, we report a case of PCMC excised with a narrow surgical margin and review the relevant literature. A 49-year-old man presented with a small cutaneous nodule of the right cheek. The mass was excised without any margin, but pathologic examination revealed histology of mucinous carcinoma. Because of this, the operative site was re-excised with a 5-mm margin, and the wound was closed using a V-Y advancement flap. Systemic work-up did not reveal other potential metastatic primary, for a final diagnosis of PCMC. We report this case of PCMC, treated with relatively narrow margin in a patient with good prognostic factors.

Keywords

References

  1. Lennox B, Pearse AG, Richards HG. Mucin-secreting tumours of the skin with special reference to the so-called mixed-salivary tumour of the skin and its relation to hidradenoma. J Pathol Bacteriol 1952;64:865-80. https://doi.org/10.1002/path.1700640418
  2. Kamalpour L, Brindise RT, Nodzenski M, Bach DQ, Veledar E, Alam M. Primary cutaneous mucinous carcinoma: a systematic review and meta-analysis of outcomes after surgery. JAMA Dermatol 2014;150:380-4. https://doi.org/10.1001/jamadermatol.2013.6006
  3. Requena L, Mengeesha Y, Kutzner H, et al. Appendageal tumors. In: LeBoit PE; International Agency for Research on Cancer; World Health Organization, et al., editors. Pathology and genetics of skin tumours. Lyon: IARC Press; 2006. p. 132-3.
  4. Adefusika JA, Pimentel JD, Chavan RN, Brewer JD. Primary mucinous carcinoma of the skin: the Mayo Clinic experience over the past 2 decades. Dermatol Surg 2015;41:201-8. https://doi.org/10.1097/DSS.0000000000000198
  5. Guadagni F, Roselli M, Cosimelli M, Spila A, Cavaliere F, Tedesco M, et al. Correlation between tumor-associated glycoprotein 72 mucin levels in tumor and serum of colorectal patients as measured by the quantitative CA 72-4 immunoassay. Cancer Res 1996;56:5293-8.

Cited by

  1. A Case of Primary Mucinous Adenocarcinoma of the Lower Eyelid vol.59, pp.2, 2018, https://doi.org/10.3341/jkos.2018.59.2.176
  2. Mucinous Adenocarcinoma of the Scalp: Primary Cutaneous Neoplasm Versus Underlying Metastatic Disease vol.6, pp.4, 2018, https://doi.org/10.1097/gox.0000000000001761